GAMMA Investing LLC Purchases 8,280,404 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

GAMMA Investing LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 56,142.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,295,153 shares of the healthcare conglomerate's stock after purchasing an additional 8,280,404 shares during the quarter. UnitedHealth Group accounts for 0.8% of GAMMA Investing LLC's investment portfolio, making the stock its 21st biggest position. GAMMA Investing LLC owned 0.91% of UnitedHealth Group worth $4,344,586,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of UNH. NewSquare Capital LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the 4th quarter worth $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group during the 4th quarter valued at approximately $32,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded up $2.91 during midday trading on Friday, hitting $301.08. 16,265,624 shares of the company's stock traded hands, compared to its average volume of 6,787,922. The firm has a fifty day moving average of $430.87 and a 200 day moving average of $494.23. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market capitalization of $273.12 billion, a price-to-earnings ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter last year, the company earned $6.91 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Stephen J. Hemsley purchased 86,700 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Wells Fargo & Company dropped their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. JPMorgan Chase & Co. lowered their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Mizuho decreased their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Truist Financial reissued a "buy" rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Oppenheimer lowered their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $441.87.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.